Department of Microbiology and Immunology, University of Louisville, Louisville, KY, USA; Ryan White Center for Pediatric Infectious Diseases and Global Health, Herman B. Wells Center for Pediatric Research, and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Ryan White Center for Pediatric Infectious Diseases and Global Health, Herman B. Wells Center for Pediatric Research, and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Curr Opin Microbiol. 2020 Dec;58:56-61. doi: 10.1016/j.mib.2020.08.006. Epub 2020 Sep 30.
Malaria continues to pose a severe threat to over half of the world's population each year. With no long-term, effective vaccine available and a growing resistance to antimalarials, there is a need for innovative methods of Plasmodium treatment. Recent evidence has pointed to a role of the composition of the gut microbiota in the severity of Plasmodium infection in both animal models and human studies. Further evidence has shown that the gut microbiota influences the adaptive immune response of the host, the arm of the immune system necessary for Plasmodium clearance, sustained Plasmodium immunity, and vaccine efficacy. Together, this illustrates the future potential of gut microbiota modulation as a novel method of preventing severe malaria.
疟疾每年仍对全球一半以上的人口构成严重威胁。由于长期缺乏有效疫苗和抗疟药物的耐药性不断增加,因此需要创新的疟原虫治疗方法。最近的证据表明,肠道微生物组的组成在动物模型和人类研究中都与疟原虫感染的严重程度有关。进一步的证据表明,肠道微生物组会影响宿主的适应性免疫反应,这是清除疟原虫、维持疟原虫免疫力和疫苗效力所必需的免疫系统的一部分。综上所述,这说明了肠道微生物组调节作为一种预防严重疟疾的新方法具有未来潜力。